TZDs are potent PPARG agonists39 and thus, the proposed role for PPARG as an inducer of steatosis in hepatocytes appears conflicting with the efficacy of TDZs in terms of reducing hepatic lipid content. This evidence concerns the gene PPARG and steatosis.